Case study: Transparent cold chain clinical supply strategy delivers better patient access model for a global drug developer

For most pharmaceutical companies conducting clinical trials on their journey to market approval has only become more challenging. It has also become more resource-intensive. To cope, much of the pharma industry turns to third party service providers to handle the complexity of delivering drugs in clinical trials to patients.

In this case study, discover how World Courier’s clinical trial supply (CTS) solution was perfectly positioned to be the first to deliver its breakthrough biologic to participants, then ensuring commercial supply to patients post-approval.